Skip to main content
BMJ Open logoLink to BMJ Open
. 2023 Oct 11;13(10):e069937. doi: 10.1136/bmjopen-2022-069937

Association between self-reported alcohol consumption and diastolic dysfunction: a cross-sectional study

Bledar Daka 1,, Louise Bennet 2, Lennart Råstam 2, Margareta I Hellgren 3, Ying Li 4, Martin Magnusson 5, Ulf Lindblad 2
PMCID: PMC10583109  PMID: 37821143

Abstract

Background and objectives

While alcohol consumption is associated with common risk factors for diastolic dysfunction the independent impact of low levels of alcohol consumption on this condition in a community setting is still unclear.

Thus, the aim of this study was to explore this association in a representative population sample employing optimal echocardiographic techniques.

Design

Cross-sectional observational study in community-based population.

Settings, participants and methods

Participants between 30 and 75 years of age were consecutively invited to a physical examination, interview, conventional echocardiography, including Tissue Velocity Imaging. Diastolic dysfunction was defined according to the European Society of Cardiology criteria, excluding subjects with ejection fraction <45%, self-reported history of heart failure or atrial fibrillation on ECG. Self-reported alcohol intake using a validated questionnaire was categorised as no intake, low and medium-high intake.

Results

In total, 500 men and 538 women (mean age 55.4±13) were successfully examined. Diastolic dysfunction was identified in 16% (79/500) of the men and 13% (58/538) of the women. The multivariable adjusted model revealed a strong and independent association between alcohol intake and diastolic dysfunction. In fact, using no alcohol intake as reference, diastolic dysfunction was independently associated with alcohol consumption in a dose-dependent fashion; low consumption, OR 2.3 (95% CI 1.3 to 4.0) and medium-high consumption OR 3.1 (95% CI 1.6 to 6.2), respectively.

Conclusion

There was a significant association between alcohol consumption and diastolic dysfunction starting already at low levels that was supported by a dose-dependent pattern. These results need confirmatory studies and are important in public health policies.

Keywords: echocardiography, preventive medicine, heart failure


Strengths and limitations of this study.

  • Echocardiography was performed in a large population-based cohort using standardised methods. The re-evaluation of a subsample by a senior cardiologist confirmed the first assessment and the consistency.

  • Detailed information on other risk factors including oral glucose tolerance test to define diabetes mellitus was available.

  • Validated questionnaires on alcohol consumption was used, however, still self-reported.

  • Finally, this was a cross-sectional observational study and no conclusions in causality can be drawn. However, randomised controlled trials in this field are and will remain difficult to perform.

Introduction

Based on WHO from 2018 about 57% of the adult population globally are alcohol consumers and 3 million deaths are attributed to alcohol consumption in 2016.1 2 A recently published meta-analysis could identify better health outcomes in people that had reported low to moderate alcohol consumption.3 On the other hand, several studies have shown that moderate levels of alcohol (ie, alcohol equalling <1 drink per day (d/d) of alcohol in women and <2 d/d in men) have a protective effect on ischaemic heart disease and chronic heart failure (CHF)1 4 while heavy episodic drinking negates from these effects.5 Interestingly, chronic excessive alcohol consumption is also reported to be associated with diastolic dysfunction,6 which is characterised by disturbed relaxation and increased preload. Diastolic dysfunction represents one out of three criteria for diastolic heart failure7 and occurs often without impaired physical performance or other symptoms. The condition is common with prevalence in community-based studies varying from a few to 30%8 9 and is associated with increase in risk to develop heart failure10

In patients with hypertension, moderate alcohol consumption have been associated with diastolic dysfunction.11 Although alcohol consumption is associated with common risk factors for diastolic dysfunction as hypertension12 and obesity13 the independent impact of low to levels of alcohol consumption on this condition in a community setting is still unclear. While there is consensus on deleterious effects of heavy drinking, the role of low alcohol consumption on cardiovascular disease (CVD) and CHF risk and diastolic dysfunction is unknown. Also, the mechanisms of a protective effect in low doses and deleterious effect in higher doses have not been explained yet.

Thus, the objective of this study was to explore the associations between alcohol intake and asymptomatic diastolic dysfunction with preserved systolic function in a population-based cohort.

Materials and methods

Subjects

This study includes data from a surveillance of the population in Vara 2002–2003, a small community with 16 000 residents in a rural area of south-western Sweden.14 The sampling, inclusion of participants and echocardiography-examination was conducted as previously described.15 Briefly, men (500) and women (538) aged 30–75 years were selected from the census register and invited to participate. Individuals below age 50 years were oversampled three times as compared with those who were older. Participation was based on conducting an echocardiography and physical examination, filling in questionnaires and returning blood samples. Subjects with ejection fraction <45%, self-reported history of heart failure, arrhythmia, aortic insufficiency or physical characteristics hindering echo were excluded from the analyses (N=20). The study profile is presented in figure 1.

Figure 1.

Figure 1

Study population in the Vara cohort 2002–2003. *Cases excluded due to at least one of the following reasons: arrhythmia/atrial fibrillation n=8, physical characteristics hindering echocardiography n=6, self-reported history of heart failure n=6, ejection fraction<45% n=2 and/or aortic insufficiency n=2.

Demographic and lifestyle data

Standardised physical examinations were performed and blood samples drawn including oral glucose tolerance tests.15 Blood pressure was measured in a lying position after 5 min rest. Two measurements were done within 1 min apart and the mean value was used. Diagnosis of hypertension was defined in accordance with international guidelines based on medical history of hypertension or three consecutive blood pressure measurements equal or higher than 140/90 mm Hg.16 Diabetes was defined based on WHO recommendations.17 Information on previous CVD was collected through questionnaires. Information on smoking habits was also collected through questionnaires and participants were categorised as never smokers, former smokers and current smokers.

Alcohol intake

Participants were asked to estimate the number of days they had been drinking alcohol the last month and the average amount of alcohol they had consumed during those days. Based on validated questionnaires18 for self-reported alcohol intake an estimation on grams per week of alcohol consumption was calculated for each participant. Based on quartiles of this estimated weekly alcohol consumption, the participants were divided into three groups. Non-drinkers were participants that reported no alcohol consumption last month. Highest quartile (>56 g/week) was defined as medium-high consumers and those with alcohol consumption ≤56 g/week were defined as low consumers. One drink of alcohol was estimated equivalent to 15 g of alcohol.19

Level of leisure time physical activity (LTPA) was self-reported in four possible levels: Sedentary LTPA, that is, mostly physically inactive, less strenuous LTPA (walks, cycling, gardening, etc) <4 hours a week (h/w); medium LTPA, that is, less strenuous LTPA>4 h/w or high LTPA, that is, strenuous LTPA (jogging, swimming, tennis, etc) ≥2 h/w.20 Due to the reduced number of individuals in the strenuous category we grouped groups 3 and 4 together and defined it as reference.

Echocardiographic methods

All participants were examined by the same senior cardiologist, using echocardiography (General Electrics VingMed S 5 System, operating with a 3.5 MHz-probe).15 The same cardiologist performed all the measurements and had no access to information on alcohol drinking habits. Data was stored in the EchoPAC system for playback analysis and measurement. Measurements for left ventricular (LV) calculations were taken from the Guidelines of the American Society of Echocardiography.21 A two-dimensional echocardiogram was formed from the left parasternal and apical windows for measurements. The ejection fraction (EF) was calculated from apical four and two chamber views with longitudinal systolic shortening mean index/atrioventricular plane displacement technique in addition to a semi-quantitative visual estimate method.22 23 The ventricular diastolic function was based on several parameters and their respective normal ranges were defined for different age categories.24 The E-wave-peak (early filling) to A-wave-peak (atrial filling), and the ratio were then determined. The isovolumetric relaxation time, from the closure of the aortic valve to the opening of the mitral valve, was also measured. To indirectly measure distensibility in the LV, the deceleration time, the peak E to baseline-slope, was measured. Tissue Velocity Imaging was used in both the septum and in the more stable lateral wall to detect pseudo-normalisation. The patient was also told to perform the Valsalva manoeuvre during registration.

Diastolic dysfunction was defined according to the recommendations of the European Society of Cardiology24 25 when evidence of abnormal LV diastolic relaxation, filling, diastolic distensibility and diastolic stiffness were found in the presence of normal or mildly reduced LV systolic function (EF≥45%). Diastolic dysfunction was categorised into three levels as: impaired relaxation, that is, early diastolic dysfunction; pseudonormal, that is, a more severe condition indicating increasing LV filling pressures or restrictive filling pattern. Diastolic dysfunction was then further dichotomised as being normal or not with impaired relaxation, pseudonormal or restrictive filling patterns categorised as diastolic dysfunction. Another senior cardiologist—not otherwise involved in the project and unaware of the findings in the first examination—reviewed the diagnostic criteria and the echocardiographic methods and re-examined a random sample (n=30) of the study sample using stored images. The results were consistent showing identical categorisation.

Left ventricular mass was defined as: LVM=0.8 × (1.04 ((LV internal dimension+posterior wall thickness+septal thickness)3 − (LV internal dimension in diastole)3)) + 0.6 g. LVM was then indexed for height2.7 (LVM-index), and left ventricular hypertrophy (LVH) was defined as LVM-index ≥47.3 g/m2.7 based on guidelines.26 27

Statistical analysis

Standard methods were used for descriptive statistics which were presented in terms of mean and SD for all continuous variables and counts with percentage of categorical variables. All the statistical analysis were performed using program R V.4.1.2. Possible confounding was addressed by stratification and multivariate analyses. Theoretical multiple logistic regressions were used to evaluate the association between diastolic dysfunction and alcohol consumption categories, with adjustments for different sets of covariates. In the theoretical models we included traditional confounding factors as age and gender. Current smoking status and LTPA are lifestyle factors with strong covariation with alcohol consumption and that can influence the risk for diastolic dysfunction. Traditional determinants of diastolic dysfunction such as hypertension, type 2 diabetes and obesity were also included in the model. Model 1 includes only age and gender as traditional confounding factors. Model 2 adds smoking status and LTPA as lifestyle factors, which could be regarded as possible confounders or risk factors for outcome. Finally, Model 3 includes hypertension, type 2 diabetes and body mass index (BMI), which could be considered as mediators or strong determinants of diastolic dysfunction.

By presenting all three models the reader will have the possibility to judge the extent to which a change of the effect measure reflects removing a confounding effect and the extent to which the change of the effect measure reflects the degree of possible mediation.

These associations were expressed as ORs with 95% CIs. All tests were two-sided and statistical significance was assumed at p<0.05.

Ethical considerations

The investigation conforms to the principles outlined in the Declaration of Helsinki. The participants provided written informed consent to their participation in the health survey, and a further written informed consent was obtained before undergoing an ultrasound-Doppler examination of the heart.

Patient and public involvement

A meeting in the study centre and the primary healthcare centre was organised prior to the start of the study. A discussion with caregivers was organised to meet their concerns and ideas for the study but also to organise the care for individuals with pathological findings in the study. An open house event for the public was organised to inform and receive questions and suggestions. The results of the study are disseminated within the healthcare centres and health professionals.

Data availability statement

The data generated in the current study are available on reasonable request, considering the sensitivity and confidentiality of the data. Due to the nature of the data, which contains personally identifiable information and sensitive information, it cannot be openly shared in a public repository.

Results

The mean age of the population was 55.4±13 years. In total, 79 of 500 men (16.5%) and 58 of 538 (12.9%) women were diagnosed with diastolic dysfunction (p=0.037). A total of 94% of the cases were categorised as impaired relaxation (74 men, 55 women) and 6% as pseudonormal (5 men, 3 women). There were no cases of severe restrictive filling patterns.

Alcohol consumption was common in both genders; men 84.5% (412/486) and women 68.8% (375/527), however, significant differences were observed between men and women with women being non-drinkers to a larger extent. In this observational study, non-drinkers were older, had higher blood pressure and had more often diabetes, however. Being allocated in one of groups based on alcohol consumption was not associated with diastolic dysfunction (p=0.500) (table 1). Meanwhile, among subjects not using alcohol, a higher rate of LVH was observed. Characteristics of the study population as well as echocardiographic characteristics related to level of alcohol intake are presented in table 1.

Table 1.

Characteristics of participants related to level of alcohol consumption

Variables Alcohol consumption P value*
Non-consumers
n=226 (22%)
Low
n=531 (53%)
Medium-high
n=254 (25%)
Diastolic dysfunction† 35 (15.5) 66 (12.4) 32 (12.6) 0.500
Age (years)‡ 55.4 (12.8) 49.5 (11.5) 48 (10.7) 0.050
Women† 152 (67.3) 289 (54.4) 85 (33.5) <0.001
BMI (kg/m2)‡ 27.8 (5.4) 26.8 (4.2) 27 (3.9) <0.001
SBP (mm Hg)‡ 128.4 (18.9) 123.6 (17.1) 123.2 (15.6) 0.001
DBP (mm Hg)‡ 71.1 (9.7) 71.1 (10.3) 72.1 (10.1) 0.300
HDL (mmol/L)‡ 1.2 (0.3) 1.3 (0.3) 1.3 (0.3) 0.100
TG (g/L)‡ 1.4 (0.7) 1.3 (0.8) 1.3 (0.7) 0.700
Level of physical activities 0.020
 Mobile 57 (25.2%) 191 (36.0%) 90 (35.4%)
 Medium 147 (65%) 312 (58.8%) 149 (58.7%)
 Sedentary 22 (9.7%) 28 (5.3%) 12 (5.9%)
Hypertension† 61 (27.0) 93 (17.5) 33 (13) <0.001
Diabetes† 29 (12.8) 34 (6.4) 10 (3.9) <0.001
Smoking habits† 39 (17.3) 92 (17.3) 54 (21.4) 0.300
E/A ratio 1.2 (0.4) 1.4 (0.4) 1.4 (0.4) <0.001
IVRT 98.4 (21.9) 91.6 (20.1) 93.2 (21.2) <0.001
Ejection fraction 72.2 (9.6) 74.4 (8.4) 74.4 (7.8) 0.005
Septal wall (cm) 1 (0.2) 0.9 (0.2) 0.9 (0.2) 0.008
Posterior wall (cm) 1 (0.3) 0.9 (0.2) 1 (0.5) 0.010
LAD (cm) 3.3 (0.5) 3.2 (0.5) 3.3 (0.5) 0.040
LV-mass (median and 5th, 95th percentiles) 37.8 (23.4, 62) 34.5 (23.8, 55.6) 35.1 (23.9, 57.5) 0.050*
LVH 52 (23.0%) 70 (13.2%) 32 (12.6%) 0.001

*P values are based analysis of variance if the variables are continuous or based on χ2 test if the variables are binary. Medium-high is defined as consumption >56 g/week and low those with alcohol consumption ≤56 g/week.

†Data is presented as counts (per cent).

‡Data are presented with mean (SD).

§

BMI, body mass index; DBP, diastolic blood pressure; E/A ratio, The ratio of peak velocity blood flow from left ventricular relaxation in early diastole (the E wave) to peak velocity flow in late diastole caused by atrial contraction (the A wave); HDL, high density lipoprotein-cholesterol; IVRT, isovolumic relaxation time; LAD, left atrial diameter; LV, left ventricular; LVH, left ventricular hypertrophy; SBP, systolic blood pressure; TG, triglycerides.

In a multivariable theoretical model, adjusted for possible confounders and mediators in the association between alcohol consumption and diastolic dysfunction, we found that alcohol consumption was significantly associated with increased risk of diastolic dysfunction. Interestingly, even low alcohol consumption was strongly associated with increased risk for diastolic dysfunction (OR=2.2 95% CI 1.3 to 3.9). The estimates were even higher for participants with moderate to high alcohol consumption (OR=3.1 95% CI 1.6 to 6.2) with a strong significant trend (p=0.001). Similar results were observed when adjustments for systolic blood pressure were included in the final models (low consumption: OR=2.3 95% CI 1.3 to 4.1; moderate to high alcohol consumption OR=3.1 95% CI 1.6 to 6.2). In another model we tested also to adjust in the final model for high density lipoprotein-cholesterol on the top of adjustments for age, gender, hypertension, type 2 diabetes, BMI, smoking habits and leisure time physical activities and the association was still strong and significant (low consumption: OR=2.4 95% CI 1.4 to 4.4; moderate to high alcohol consumption OR=3.4 95% CI 1.7 to 6.9). Exploring in the same models the association between alcohol consumption and left atrial diameter no significant differences were observed between group with no consumption and groups with low and moderate to high (age and sex adjustments: low consumption: mean difference (cm)=−0.04 95% CI −0.11 to 0.02; moderate to high alcohol consumption mean difference (cm)=−0.02 95% CI −0.10 to 0.07; fully adjusted model: low consumption: mean difference (cm)=−0.02 95% CI −0.08 to 0.04; moderate to high alcohol consumption mean difference (cm)=0.0 95% CI −0.07 to 0.08). There were no significant differences in these associations were observed between men and women (p for interaction >0.25). High age, male sex, hypertension, high BMI and a low level of leisure time physical activity were all also independently associated with diastolic dysfunction (table 2).

Table 2.

Association between risk factors and diastolic dysfunction

OR (95% CI)
Model 1
Age 1.16 (1.13 to 1.19)
Men vs women 1.34 (0.87 to 2.07)
Alcohol consumption
 None 1 (ref)
 Low vs none 1.82 (1.08 to 3.12)
 High vs none 2.39 (1.26 to 4.58)
Model 2
Age 1.16 (1.13 to 1.19)
Men vs women 1.46 (0.94 to 2.27)
Current smoking 1.39 (0.78 to 2.42)
Physical activity
 Active 1 (ref)
 Medium vs active 1.6 (0.97 to 2.69)
 Sedentary vs active 4.4 (1.93 to 9.96)
Alcohol consumption 1 (ref)
Low vs non 2.03 (1.19 to 3.5)
High vs non 2.68 (1.4 to 5.19)
Model 3
Age 1.14 (1.11 to 1.18)
Men vs women 1.63 (1.02 to 2.63)
BMI 1.07 (1.01 to 1.11)
Hypertension 2.68 (1.65 to 4.33)
Type 2 diabetes 1.88 (1.00 to 3.53)
Current smoking 1.76 (0.96 to 3.15)
Leisure time physical activity
Medium vs active 1.28 (0.75 to 2.23)
Sedentary vs active 2.82 (1.15 to 6.84)
Alcohol consumption
 None 1 (ref)
 Low vs none 2.25 (1.29 to 4.02)
 High vs none 3.06 (1.55 to 6.15)

Multivariable logistic regression analyses are used to investigate the association between explanatory variables and diastolic dysfunction. In model 1 adjustments for age and gender, in model 2 adjustments for age, gender, current smoking, leisure time physical activities, in model 3 adjustments for age, gender, BMI, hypertension, type 2 diabetes, current smoking, leisure time physical activities are computed. Women are the reference group in the analyses men versus women and physically active group is the reference in the analyses of leisure time physical activity.

BMI, body mass index.

Similar analyses were computed using LVH as outcome, but no significant association was found with alcohol consumption (table 3).

Table 3.

Association between risk factors and left ventricular hypertrophy

OR (95% CI)
Age 1.08 (1.06 to 1.1)
Men vs women 1.16 (0.75 to 1.78)
BMI 1.16 (1.11 to 1.22)
Hypertension 3.20 (2.05 to 5.01)
Type 2 diabetes 1.30 (0.70 to 2.38)
Current smoking 1.53 (0.89 to 2.57)
Leisure time physical activity
 Medium vs mobile 0.96 (0.60 to 1.56)
 Sedentary vs mobile 1.18 (0.50 to 2.69)
Alcohol consumption
 Non-drinkers 1 (ref)
 Low vs non 1.08 (0.59 to 1.98)
 High vs non 1.53 (0.89 to 2.57)

Multivariable logistic regression analyses are used to investigate the association between explanatory variables and left ventricular hypertrophy.

BMI, body mass index.

Discussion

In this cross-sectional observational study, we found a strong and independent association between self-reported alcohol consumption and diastolic dysfunction. Interestingly, our data show an increased risk of having diastolic dysfunction already in subjects with low level of alcohol consumption. Moreover, in gender specific analyses no gender differences were observed suggesting a similar effect of alcohol in both men and women. Despite these findings, no significant association between alcohol intake and LVH were observed. Like previous observations, age, gender, hypertension, leisure time physical activity levels and BMI were all strongly and independently associated with diastolic dysfunction.

These findings are not in line with most of the observations on the role of alcohol in heart failure. In fact, population-based studies have shown that moderate levels of alcohol consumption (ie, <1 d/d in women and <2 d/d in men) have a protective effect on ischaemic heart disease and decreases the incidence of CHF. 1 3 28 The beneficial effects of a low to moderate amount of alcoholic intake are not reported by all epidemiological studies.29 30 A ‘healthy cohort effect’ is reported as one plausible explanation to the favourable effects of moderate consumption29 30 where the confounding effects of, for example, physical activity, mental health, psychosocial, socioeconomic and social network-related factors seldom are accounted for.30 Moreover, in a recent observation in HUNT study31 no protective effect of low-alcohol consumption on LV function was observed, however, a positive linear association was observed between alcohol consumption and LVM and end diastolic diameter. The findings of HUNT-study are in line with our findings however the significance in the association was lost in their multivariable analyses. Interestingly, before the adjustments in our cohort higher prevalence of diastolic dysfunction was observed in non-drinkers. These differences were not significant. The same group had also higher age, lower level of physical activities, higher systolic blood pressure and higher prevalence of hypertension and diabetes. It was first after the adjustments for these factors that a positive linear association between alcohol consumption and diastolic dysfunction was observed. These findings suggest no protective effect of alcohol at low levels. Also, alcohol seems not to be related with better diastolic dysfunction, but healthy and younger subjects are more prone to drink alcohol and they have of course better diastolic function but not of alcohol consumption.

Several alcohol metabolites are identified as particularly toxic to the myocardium: ethanol, acetaldehyde (the metabolic product of alcohol) and fatty acid ethyl esters.32 33 Alcohol also impairs the transport of calcium ions from the sarcoplasma to the sarcoplasmatic reticulum34 35 resulting in diastolic dysfunction characterised by delayed myocardial relaxation36 and impaired LV diastolic filling. Moderate versus high doses of alcohol affect myocardial function differently through oxidative stress, haemostatic factors, levels of C-reactive protein, interleukins and tumour necrosis factor alpha.29

There have been observations that suggest that patterns of drinking and food intake might explain at least partially the damages of alcohol in myocardium.5 37 38 In fact, in the Mediterranean countries with a low prevalence of CVD, alcohol is commonly consumed with meals as compared with Russia with a high prevalence of CVD where binge drinking is much more frequent.30 However, some studies have shown there is evidence that alcoholic cardiomyopathy can be developed even in the absence of malnutrition39 while these deleterious effects are exaggerated.40 41

Interestingly, our results did not show any significant association with LVH. One reason for the lack of association might be the relatively low number of individuals with high consumption in this cohort. Measurable structural remodelling might need a higher level of alcohol consumption. In fact, a large population study in South Korea with a significantly larger number of participants compared with our study, could find a strong association between alcohol consumption and LVH.42

Strengths and limitations

Echocardiography was used in this large population-based cohort using standardised age-dependent criteria to identify diastolic dysfunction based on recommendations by international expert groups. The re-evaluation of a subsample by a senior cardiologist confirmed the first assessment and the consistency in assessment of prevalence of diastolic dysfunction and in identified risk factors between our findings and other comprehensive surveys using Doppler techniques, lend further support to the validity of our data.

The characteristics of alcohol consumers and prevalence of alcohol consumption was in accordance with other comparable community-based surveys.43 44 This, however, might be a source of underestimation of the alcohol consumption. In fact, in several studies there is an underestimation of self-reported alcohol consumption45 and there is a need for more objective and reliable measures of alcohol consumption. However, the underestimation should be more frequent and mostly in the group with higher consumption. This would not have an impact on our results in the association found between low alcohol consumption and diastolic dysfunction. Moreover, the findings are based on a rural population in Sweden and differences in these associations might appear when other populations are considered, however the consistency of the results with previous findings indicate that these findings might apply in other populations. Finally, this was a cross-sectional observation and no conclusions in causality can be drawn and the residual confounding is not possible to rule out.

Conclusion

Our study revealed a significant association between alcohol consumption and diastolic dysfunction starting already at low levels that was supported by a dose-dependent pattern. Additional prospective surveys with adequate measurement of alcohol consumption and possible confounders are needed to improve our understanding of the underlying relationships and mechanisms. Our results might be of importance in the development of public health policies and preventive strategies.

Supplementary Material

Reviewer comments
Author's manuscript

Acknowledgments

We are indebted to all participants in the Vara Cohort. Without them this study would have not been possible. The Knut and Alice Wallenberg foundation is recognised for generous support.

Footnotes

Contributors: All authors read and approved the final manuscript. Research idea and study design: LB, BD, UL, MH. Data acquisition: UL, LR, BD, MH. Data analysis and interpretation: LB, UL, BD, MM, MH. Statistical analyses: LB, BD, YL, UL. BD is responsible for the overall content. Each author contributed important intellectual content during manuscript drafting or revision, accepts personal accountability for the author’s own contributions and agrees to ensure that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.

Funding: This work was supported by: The Swedish Science Council; Sahlgrenska Academy, University of Gothenburg; Skaraborg Institute; The Health & Medical Care Committee of the Regional Executive Board of the Region Västragötalands region VGFOUREG-86294, VGFOUREG-969459, ALFGBG-966255, ALFGBG-971147; Skaraborg Primary Care; Skane Region; Lund University; University Hospital of Malmoe donation Foundation; Påhlsson Foundation; Crafoord Foundation; Lundberg Foundation, the Swedish Heart and Lung foundation and the Wallenberg Center for Molecular Medicine, Lund University; and Lund University. The funding source was not involved in the work with the article.

Competing interests: None declared.

Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

Provenance and peer review: Not commissioned; externally peer reviewed.

Data availability statement

Data are available upon reasonable request. Data are available upon reasonable request as it contains pseudonimised information.

Ethics statements

Patient consent for publication

Not applicable.

Ethics approval

This study involves human participants and was approved by Research ethics committee at the University of Gothenburg DNR Ö199-01. Participants gave informed consent to participate in the study before taking part.

References

  • 1.Djoussé L, Gaziano JM. Alcohol consumption and risk of heart failure in the physicians' health study I. Circulation 2007;115:34–9. 10.1161/CIRCULATIONAHA.106.661868 [DOI] [PubMed] [Google Scholar]
  • 2.World Health Organization . Management of Substance Abuse Team. Global status report on alcohol and health, pvolumes. Geneva, Switzerland: World Health Organization, 2018. [Google Scholar]
  • 3.Zhong L, Chen W, Wang T, et al. Alcohol and health outcomes: an umbrella review of meta-analyses base on prospective cohort studies. Front Public Health 2022;10:859947. 10.3389/fpubh.2022.859947 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Larsson SC, Wallin A, Wolk A. Alcohol consumption and risk of heart failure: meta-analysis of 13 prospective studies. Clin Nutr 2018;37:1247–51. 10.1016/j.clnu.2017.05.007 [DOI] [PubMed] [Google Scholar]
  • 5.Murray RP, Connett JE, Tyas SL, et al. Alcohol volume, drinking pattern, and cardiovascular disease morbidity and mortality: is there a U-shaped function Am J Epidemiol 2002;155:242–8. 10.1093/aje/155.3.242 [DOI] [PubMed] [Google Scholar]
  • 6.Lazarević AM, Nakatani S, Nesković AN, et al. Early changes in left ventricular function in chronic asymptomatic alcoholics: relation to the duration of heavy drinking. J Am Coll Cardiol 2000;35:1599–606. 10.1016/s0735-1097(00)00565-9 [DOI] [PubMed] [Google Scholar]
  • 7.How to diagnose diastolic heart failure. European study group on diastolic heart failure. Eur Heart J 1998;19:990–1003. 10.1053/euhj.1998.1057 [DOI] [PubMed] [Google Scholar]
  • 8.Fischer M, Baessler A, Hense HW, et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003;24:320–8. 10.1016/s0195-668x(02)00428-1 [DOI] [PubMed] [Google Scholar]
  • 9.Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194–202. 10.1001/jama.289.2.194 [DOI] [PubMed] [Google Scholar]
  • 10.Vogel MW, Slusser JP, Hodge DO, et al. The natural history of preclinical diastolic dysfunction: a population-based study. Circ Heart Fail 2012;5:144–51. 10.1161/CIRCHEARTFAILURE.110.959668 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Catena C, Colussi G, Verheyen ND, et al. Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients. Hypertension 2016;68:1208–16. 10.1161/HYPERTENSIONAHA.116.08145 [DOI] [PubMed] [Google Scholar]
  • 12.Liu F, Liu Y, Sun X, et al. Race- and sex-specific association between alcohol consumption and hypertension in 22 cohort studies: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2020;30:1249–59. 10.1016/j.numecd.2020.03.018 [DOI] [PubMed] [Google Scholar]
  • 13.Chakraborty S. Analysis of NHANES 1999-2002 data reveals noteworthy Association of alcohol consumption with obesity. Ann Gastroenterol 2014;27:250–7. [PMC free article] [PubMed] [Google Scholar]
  • 14.Larsson CA, Krøll L, Bennet L, et al. Leisure time and occupational physical activity in relation to obesity and insulin resistance: a population-based study from the Skaraborg project in Sweden. Metabolism 2012;61:590–8. 10.1016/j.metabol.2011.09.010 [DOI] [PubMed] [Google Scholar]
  • 15.Ingelsson E, Bennet L, Ridderstråle M, et al. The Ppargc1A Gly482Ser polymorphism is associated with left ventricular diastolic dysfunction in men. BMC Cardiovasc Disord 2008;8:37. 10.1186/1471-2261-8-37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.World health organization-International society of hypertension . Guidelines for the management of hypertension. J Hypertens (Los Angel) 1999;17:151. 10.1097/00004872-199917020-00001 [DOI] [PubMed] [Google Scholar]
  • 17.Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539–53. 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S [DOI] [PubMed] [Google Scholar]
  • 18.Göransson M, Hanson BS. How much can data on days with heavy drinking decrease the underestimation of true alcohol consumption J Stud Alcohol 1994;55:695–700. 10.15288/jsa.1994.55.695 [DOI] [PubMed] [Google Scholar]
  • 19.Bantle JP, Wylie-Rosett J, Albright AL, et al. Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association. Diabetes Care 2006;29:2140–57. 10.2337/dc06-9914 [DOI] [PubMed] [Google Scholar]
  • 20.Nyholm M, Gullberg B, Haglund B, et al. Higher education and more physical activity limit the development of obesity in a Swedish rural population. Int J Obes (Lond) 2008;32:533–40. 10.1038/sj.ijo.0803725 [DOI] [PubMed] [Google Scholar]
  • 21.Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s guidelines and standards committee and the chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440–63. 10.1016/j.echo.2005.10.005 [DOI] [PubMed] [Google Scholar]
  • 22.Jarnert C, Mejhert M, Ring M, et al. Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique. Eur J Heart Fail 2000;2:151–60. 10.1016/s1388-9842(00)00075-1 [DOI] [PubMed] [Google Scholar]
  • 23.Gudmundsson P, Rydberg E, Winter R, et al. Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods. Int J Cardiol 2005;101:209–12. 10.1016/j.ijcard.2004.03.027 [DOI] [PubMed] [Google Scholar]
  • 24.Oh JK, Appleton CP, Hatle LK, et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997;10:246–70. 10.1016/s0894-7317(97)70062-2 [DOI] [PubMed] [Google Scholar]
  • 25.Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur Heart J 2005;26:1115–40. 10.1093/eurheartj/ehi204 [DOI] [PubMed] [Google Scholar]
  • 26.de Simone G, Devereux RB, Chinali M, et al. Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the strong heart study. Nutr Metab Cardiovasc Dis 2009;19:98–104. 10.1016/j.numecd.2008.04.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Krauser DG, Devereux RB. Ventricular hypertrophy and hypertension: prognostic elements and implications for management. Herz 2006;31:305–16. 10.1007/s00059-006-2819-5 [DOI] [PubMed] [Google Scholar]
  • 28.Walsh CR, Larson MG, Evans JC, et al. Alcohol consumption and risk for congestive heart failure in the Framingham heart study. Ann Intern Med 2002;136:181–91. 10.7326/0003-4819-136-3-200202050-00005 [DOI] [PubMed] [Google Scholar]
  • 29.Bau PFD, Bau CHD, Rosito GA, et al. Alcohol consumption, cardiovascular health, and endothelial function markers. Alcohol 2007;41:479–88. 10.1016/j.alcohol.2007.08.004 [DOI] [PubMed] [Google Scholar]
  • 30.Fuchs FD, Chambless LE. Is the cardioprotective effect of alcohol real Alcohol 2007;41:399–402. 10.1016/j.alcohol.2007.05.004 [DOI] [PubMed] [Google Scholar]
  • 31.Gémes K, Janszky I, Strand LB, et al. Light-moderate alcohol consumption and left ventricular function among healthy, middle-aged adults: the HUNT study. BMJ Open 2018;8:e020777. 10.1136/bmjopen-2017-020777 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Beckemeier ME, Bora PS. Fatty acid ethyl esters: potentially toxic products of myocardial ethanol metabolism. J Mol Cell Cardiol 1998;30:2487–94. 10.1006/jmcc.1998.0812 [DOI] [PubMed] [Google Scholar]
  • 33.Ren J, Wold LE. Mechanisms of alcoholic heart disease. Ther Adv Cardiovasc Dis 2008;2:497–506. 10.1177/1753944708095137 [DOI] [PubMed] [Google Scholar]
  • 34.Cofán M, Nicolás JM, Fernández-Solà J, et al. Acute ethanol treatment decreases intracellular calcium-ion transients in Mouse single Skeletal muscle fibres in vitro. Alcohol Alcohol 2000;35:134–8. 10.1093/alcalc/35.2.134 [DOI] [PubMed] [Google Scholar]
  • 35.Noren GR, Staley NA, Einzig S, et al. Alcohol-induced congestive cardiomyopathy: an animal model. Cardiovasc Res 1983;17:81–7. 10.1093/cvr/17.2.81 [DOI] [PubMed] [Google Scholar]
  • 36.Kupari M, Koskinen P, Suokas A, et al. Left ventricular filling impairment in asymptomatic chronic alcoholics. Am J Cardiol 1990;66:1473–7. 10.1016/0002-9149(90)90537-b [DOI] [PubMed] [Google Scholar]
  • 37.Urquiaga I, Guasch V, Marshall G, et al. Effect of mediterranean and occidental diets, and red wine, on plasma fatty acids in humans. Biol Res 2004;37:253–61. 10.4067/s0716-97602004000200012 [DOI] [PubMed] [Google Scholar]
  • 38.Britton A, McKee M. The relation between alcohol and cardiovascular disease in Eastern Europe: explaining the paradox. J Epidemiol Community Health 2000;54:328–32. 10.1136/jech.54.5.328 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Urbano-Marquez A, Estruch R, Navarro-Lopez F, et al. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 1989;320:409–15. 10.1056/NEJM198902163200701 [DOI] [PubMed] [Google Scholar]
  • 40.Fernández-Solà J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol 2015;12:576–87. 10.1038/nrcardio.2015.91 [DOI] [PubMed] [Google Scholar]
  • 41.Piano MR, Phillips SA. Alcoholic cardiomyopathy: pathophysiologic insights. Cardiovasc Toxicol 2014;14:291–308. 10.1007/s12012-014-9252-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Park SK, Moon K, Ryoo JH, et al. The association between alcohol consumption and left ventricular diastolic function and geometry change in general Korean population. Eur Heart J Cardiovasc Imaging 2018;19:271–8. 10.1093/ehjci/jex091 [DOI] [PubMed] [Google Scholar]
  • 43.Bostrom G, Nykvist K. Lifestyle and health (in Swedish). The National Institute of Public Health in Sweden, 2004. Available: http://www.fhi.se/upload/ar2005/rapporter/r200448levnadsvanorhalsa0504.pdf [Google Scholar]
  • 44.Wilsgaard T, Jacobsen BK. Lifestyle factors and incident metabolic syndrome. The Tromso study 1979-2001. Diabetes Res Clin Pract 2007;78:217–24. 10.1016/j.diabres.2007.03.006 [DOI] [PubMed] [Google Scholar]
  • 45.Stockwell T, Zhao J, Sherk A, et al. Underestimation of alcohol consumption in cohort studies and implications for alcohol’s contribution to the Global Burden of Disease. Addiction 2018;113:2245–9. 10.1111/add.14392 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Reviewer comments
Author's manuscript

Data Availability Statement

The data generated in the current study are available on reasonable request, considering the sensitivity and confidentiality of the data. Due to the nature of the data, which contains personally identifiable information and sensitive information, it cannot be openly shared in a public repository.

Data are available upon reasonable request. Data are available upon reasonable request as it contains pseudonimised information.


Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES